{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T08:09:06Z","timestamp":1793088546197,"version":"4.5.0"},"reference-count":149,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,6,6]],"date-time":"2027-06-06T00:00:00Z","timestamp":1812240000000},"content-version":"am","delay-in-days":370,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100011889","name":"Diamond Light Source Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011889","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["MG36899-2"],"award-info":[{"award-number":["MG36899-2"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["MG33359-1"],"award-info":[{"award-number":["MG33359-1"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["CBET 1829310"],"award-info":[{"award-number":["CBET 1829310"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Biomaterialia"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.actbio.2026.04.054","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T23:38:44Z","timestamp":1777592324000},"page":"378-393","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Bone fragility persists in long-term bisphosphonate-treated oim mice despite sex-specific changes in bone quality"],"prefix":"10.1016","volume":"217","author":[{"given":"Asier","family":"Mu\u00f1oz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-1569-019X","authenticated-orcid":false,"given":"Aimar","family":"Silvan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8103-4795","authenticated-orcid":false,"given":"Alessandra","family":"Carriero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.actbio.2026.04.054_bib0001","doi-asserted-by":"crossref","unstructured":"Marini J.C., Cabral W.A. Osteogenesis imperfecta. Genetics of bone biology and skeletal disease. 2018:397\u2013420.","DOI":"10.1016\/B978-0-12-804182-6.00023-X"},{"issue":"2","key":"10.1016\/j.actbio.2026.04.054_bib0002","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1136\/jmg.16.2.101","article-title":"Genetic heterogeneity in osteogenesis imperfecta","volume":"16","author":"Sillence","year":"1979","journal-title":"J. Med. Genet."},{"issue":"5","key":"10.1016\/j.actbio.2026.04.054_bib0003","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.049398","article-title":"Dissecting the phenotypic variability of osteogenesis imperfecta","volume":"15","author":"Garibaldi","year":"2022","journal-title":"Dis. Model Mech."},{"key":"10.1016\/j.actbio.2026.04.054_bib0004","first-page":"41","article-title":"Animal models of osteogenesis imperfecta: applications in clinical research","volume":"8","author":"Enderli","year":"2016","journal-title":"Orthop. Res. Rev."},{"issue":"9","key":"10.1016\/j.actbio.2026.04.054_bib0005","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/nrendo.2011.81","article-title":"New perspectives on osteogenesis imperfecta","volume":"7","author":"Forlino","year":"2011","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.actbio.2026.04.054_bib0006","series-title":"Nelson Textbook of Pediatrics","first-page":"2336","article-title":"Osteogenesis imperfecta","author":"Marini","year":"2004"},{"issue":"5","key":"10.1016\/j.actbio.2026.04.054_bib0007","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1007\/s11914-021-00696-6","article-title":"Poor bone matrix quality: what can be done about it?","volume":"19","author":"Mu\u00f1oz","year":"2021","journal-title":"Curr. Osteoporos. Rep."},{"key":"10.1016\/j.actbio.2026.04.054_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.jposna.2024.100054","article-title":"Bone health: quality vs. quantity","volume":"7","author":"Docaj","year":"2024","journal-title":"J. Pediatr. Orthop. Soc. N. Am."},{"issue":"343","key":"10.1016\/j.actbio.2026.04.054_bib0009","first-page":"235","article-title":"The Nicholas Andry Award-1996. The molecular pathology of osteogenesis imperfecta","author":"Cole","year":"1997","journal-title":"Clin. Orthop. Relat. Res."},{"issue":"401","key":"10.1016\/j.actbio.2026.04.054_bib0010","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/00003086-200208000-00003","article-title":"Advances in osteogenesis imperfecta","volume":"401","author":"Cole","year":"2002","journal-title":"Clin. Orthop. Relat. Res."},{"key":"10.1016\/j.actbio.2026.04.054_bib0011","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.bone.2014.09.003","article-title":"Increased intra-cortical porosity reduces bone stiffness and strength in pediatric patients with osteogenesis imperfecta","volume":"69","author":"Vardakastani","year":"2014","journal-title":"Bone"},{"issue":"4","key":"10.1016\/j.actbio.2026.04.054_bib0012","doi-asserted-by":"crossref","first-page":"225","DOI":"10.5435\/00124635-199807000-00004","article-title":"Osteogenesis imperfecta","volume":"6","author":"Kocher","year":"1998","journal-title":"JAAOS-J. Am. Acad. Orthop. Surg."},{"issue":"1","key":"10.1016\/j.actbio.2026.04.054_bib0013","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-20169-9","article-title":"Treatments for hearing loss in osteogenesis imperfecta: a systematic review and meta-analysis on their efficacy","volume":"12","author":"Ugarteburu","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.actbio.2026.04.054_bib0014","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/BF00350961","article-title":"Radiological manifestations of bisphosphonate treatment with APD in a child suffering from osteogenesis imperfecta","volume":"16","author":"Devogelaer","year":"1987","journal-title":"Skelet. Radiol."},{"issue":"6","key":"10.1016\/j.actbio.2026.04.054_bib0015","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S8756-3282(00)00269-6","article-title":"Static and dynamic bone histomorphometry in children with osteogenesis imperfecta","volume":"26","author":"Rauch","year":"2000","journal-title":"Bone"},{"issue":"3","key":"10.1016\/j.actbio.2026.04.054_bib0016","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1203\/00006450-198303000-00007","article-title":"Increased bone turnover with decreased bone formation by osteoblasts in children with osteogenesis imperfecta tarda","volume":"17","author":"Baron","year":"1983","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.actbio.2026.04.054_bib0017","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s11657-011-0054-z","article-title":"Bone mass, bone markers and prevalence of fractures in adults with osteogenesis imperfecta","volume":"6","author":"Wekre","year":"2011","journal-title":"Arch. Osteoporos."},{"key":"10.1016\/j.actbio.2026.04.054_bib0018","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s00198-007-0540-8","article-title":"Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy","volume":"19","author":"Russell","year":"2008","journal-title":"Osteoporos. Int."},{"issue":"5","key":"10.1016\/j.actbio.2026.04.054_bib0019","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.beem.2008.07.001","article-title":"Bisphosphonates: how do they work?","volume":"22","author":"Papapoulos","year":"2008","journal-title":"Best Pract. Res. Clin. Endocrinol. Metabol."},{"issue":"1","key":"10.1016\/j.actbio.2026.04.054_bib0020","first-page":"S315","article-title":"Alendronate in the treatment of osteogenesis imperfecta","volume":"16","author":"Vyskocil","year":"2001","journal-title":"J. Bone Miner. Res."},{"issue":"10","key":"10.1016\/j.actbio.2026.04.054_bib0021","article-title":"Bisphosphonate therapy for osteogenesis imperfecta","volume":"2016","author":"Dwan","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"issue":"1","key":"10.1016\/j.actbio.2026.04.054_bib0022","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1359\/jbmr.2003.18.1.126","article-title":"Intravenous neridronate in adults with osteogenesis imperfecta","volume":"18","author":"Adami","year":"2003","journal-title":"J. Bone Miner. Res."},{"issue":"5\u20136","key":"10.1016\/j.actbio.2026.04.054_bib0023","first-page":"485","article-title":"Safety and efficacy of a 1-year treatment with zoledronic acid compared with pamidronate in children with osteogenesis imperfecta","volume":"25","author":"Barros","year":"2012","journal-title":"J. Pediatr. Endocrinol. Metabol."},{"issue":"1","key":"10.1016\/j.actbio.2026.04.054_bib0024","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1359\/jbmr.090712","article-title":"A randomized, controlled dose-ranging study of risedronate in children with moderate and severe osteogenesis imperfecta","volume":"25","author":"Bishop","year":"2010","journal-title":"J. Bone Miner. Res."},{"issue":"9902","key":"10.1016\/j.actbio.2026.04.054_bib0025","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1016\/S0140-6736(13)61091-0","article-title":"Risedronate in children with osteogenesis imperfecta: a randomised, double-blind, placebo-controlled trial","volume":"382","author":"Bishop","year":"2013","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.actbio.2026.04.054_bib0026","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1359\/JBMR.051015","article-title":"Effects of oral alendronate on BMD in adult patients with osteogenesis imperfecta: a 3-year randomized placebo-controlled trial","volume":"21","author":"Chevrel","year":"2006","journal-title":"J. Bone Miner. Res."},{"issue":"1","key":"10.1016\/j.actbio.2026.04.054_bib0027","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1359\/JBMR.051006","article-title":"Two-year clinical trial of oral alendronate versus intravenous pamidronate in children with osteogenesis imperfecta","volume":"21","author":"DiMeglio","year":"2006","journal-title":"J. Bone Miner. Res."},{"issue":"5","key":"10.1016\/j.actbio.2026.04.054_bib0028","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1359\/JBMR.041232","article-title":"Intravenous neridronate in children with osteogenesis imperfecta: a randomized controlled study","volume":"20","author":"Gatti","year":"2005","journal-title":"J. Bone Miner. Res."},{"issue":"6","key":"10.1016\/j.actbio.2026.04.054_bib0029","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1359\/JBMR.050109","article-title":"Controlled trial of pamidronate in children with types III and IV osteogenesis imperfecta confirms vertebral gains but not short-term functional improvement","volume":"20","author":"Letocha","year":"2005","journal-title":"J. Bone Miner. Res."},{"issue":"7","key":"10.1016\/j.actbio.2026.04.054_bib0030","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1359\/jbmr.090213","article-title":"Risedronate in the treatment of mild pediatric osteogenesis imperfecta: a randomized placebo-controlled study","volume":"24","author":"Rauch","year":"2009","journal-title":"J. Bone Miner. Res."},{"issue":"9419","key":"10.1016\/j.actbio.2026.04.054_bib0031","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/S0140-6736(04)16101-1","article-title":"Skeletal effects and functional outcome with olpadronate in children with osteogenesis imperfecta: a 2-year randomised placebo-controlled study","volume":"363","author":"Sakkers","year":"2004","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.actbio.2026.04.054_bib0032","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1159\/000381713","article-title":"Efficacy and safety of bisphosphonate therapy in children with osteogenesis imperfecta: a systematic review","volume":"84","author":"Rijks","year":"2015","journal-title":"Horm. Res. Paediatr."},{"key":"10.1016\/j.actbio.2026.04.054_bib0033","doi-asserted-by":"crossref","first-page":"3427","DOI":"10.1007\/s00198-016-3723-3","article-title":"Osteogenesis imperfecta in children and adolescents\u2014new developments in diagnosis and treatment","volume":"27","author":"Trejo","year":"2016","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.actbio.2026.04.054_bib0034","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s00223-017-0236-9","article-title":"Long-term effects of neridronate in adults with osteogenesis imperfecta: an observational three-year Italian study","volume":"100","author":"Viapiana","year":"2017","journal-title":"Calcif. Tissue Int."},{"issue":"6","key":"10.1016\/j.actbio.2026.04.054_bib0035","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1097\/01.bpo.0000176162.78980.ed","article-title":"Impact of alendronate on quality of life in children with osteogenesis imperfecta","volume":"25","author":"Seikaly","year":"2005","journal-title":"J. Pediatr. Orthop."},{"key":"10.1016\/j.actbio.2026.04.054_bib0036","article-title":"Alendronate in the treatment of pediatric osteogenesis imperfecta","author":"Glorieux","year":"2004","journal-title":"J. Bone Miner. Res."},{"issue":"5","key":"10.1016\/j.actbio.2026.04.054_bib0037","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1002\/jbmr.2410","article-title":"Bisphosphonates for the prevention of fractures in osteogenesis imperfecta: meta-analysis of placebo-controlled trials","volume":"30","author":"Hald","year":"2015","journal-title":"J. Bone Miner. Res."},{"issue":"4","key":"10.1016\/j.actbio.2026.04.054_bib0038","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1210\/jc.2005-2413","article-title":"Pamidronate in children and adolescents with osteogenesis imperfecta: effect of treatment discontinuation","volume":"91","author":"Rauch","year":"2006","journal-title":"J. Clin. Endocrinol. Metabol."},{"issue":"2","key":"10.1016\/j.actbio.2026.04.054_bib0039","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1210\/jc.2010-0636","article-title":"Alendronate for the treatment of pediatric osteogenesis imperfecta: a randomized placebo-controlled study","volume":"96","author":"Ward","year":"2011","journal-title":"J. Clin. Endocrinol. Metabol."},{"issue":"2","key":"10.1016\/j.actbio.2026.04.054_bib0040","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jpeds.2006.03.013","article-title":"Early bisphosphonate treatment in infants with severe osteogenesis imperfecta","volume":"149","author":"Antoniazzi","year":"2006","journal-title":"J. Pediatr."},{"issue":"19","key":"10.1016\/j.actbio.2026.04.054_bib0041","first-page":"3049","article-title":"Benefit of infusions with ibandronate treatment in children with osteogenesis imperfecta","volume":"124","author":"Mei","year":"2011","journal-title":"Chin. Med. J."},{"issue":"7","key":"10.1016\/j.actbio.2026.04.054_bib0042","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1210\/clinem\/dgad035","article-title":"Approach to the patient: pharmacological therapies for fracture risk reduction in adults with osteogenesis imperfecta","volume":"108","author":"Liu","year":"2023","journal-title":"J. Clin. Endocrinol. Metabol."},{"issue":"2","key":"10.1016\/j.actbio.2026.04.054_bib0043","first-page":"105","article-title":"Alendronate treatment in children with osteogenesis imperfecta","volume":"45","author":"Akcay","year":"2008","journal-title":"Indian Pediatr."},{"issue":"4","key":"10.1016\/j.actbio.2026.04.054_bib0044","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1111\/os.12611","article-title":"Oral bisphosphonate therapy for Osteogenesis Imperfecta: a systematic review and meta-analysis of six randomized placebo-controlled trials","volume":"12","author":"Ying","year":"2020","journal-title":"Orthop. Surg."},{"issue":"3","key":"10.1016\/j.actbio.2026.04.054_bib0045","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.bone.2006.10.010","article-title":"Osteogenesis imperfecta type VI in childhood and adolescence: effects of cyclical intravenous pamidronate treatment","volume":"40","author":"Land","year":"2007","journal-title":"Bone"},{"issue":"33","key":"10.1016\/j.actbio.2026.04.054_bib0046","doi-asserted-by":"crossref","first-page":"8722","DOI":"10.1073\/pnas.1704460114","article-title":"Atypical fracture with long-term bisphosphonate therapy is associated with altered cortical composition and reduced fracture resistance","volume":"114","author":"Lloyd","year":"2017","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.actbio.2026.04.054_bib0047","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.bone.2015.08.002","article-title":"Alendronate treatment alters bone tissues at multiple structural levels in healthy canine cortical bone","volume":"81","author":"Acevedo","year":"2015","journal-title":"Bone"},{"issue":"4","key":"10.1016\/j.actbio.2026.04.054_bib0048","article-title":"Osteoporosis treatments affect bone matrix maturation in a rat model of induced cortical remodeling","volume":"4","author":"Ross","year":"2020","journal-title":"J. Bone Miner. Res. Plus"},{"issue":"3","key":"10.1016\/j.actbio.2026.04.054_bib0049","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.bone.2011.12.007","article-title":"Increased susceptibility to microdamage in Brtl\/+ mouse model for osteogenesis imperfecta","volume":"50","author":"Davis","year":"2012","journal-title":"Bone"},{"issue":"5","key":"10.1016\/j.actbio.2026.04.054_bib0050","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/s00223-008-9131-8","article-title":"Alendronate reduces bone toughness of ribs without significantly increasing microdamage accumulation in dogs following 3 years of daily treatment","volume":"82","author":"Allen","year":"2008","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.actbio.2026.04.054_bib0051","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.bone.2014.10.010","article-title":"Duration-dependent effects of clinically relevant oral alendronate doses on cortical bone toughness in beagle dogs","volume":"71","author":"Burr","year":"2015","journal-title":"Bone"},{"issue":"10","key":"10.1016\/j.actbio.2026.04.054_bib0052","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1002\/jor.20895","article-title":"Effects of 1 to 3 years' treatment with alendronate on mechanical properties of the femoral shaft in a canine model: implications for subtrochanteric femoral fracture risk","volume":"27","author":"Burr","year":"2009","journal-title":"Journal of Orthopaedic Research"},{"issue":"5","key":"10.1016\/j.actbio.2026.04.054_bib0053","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1203\/00006450-200211000-00010","article-title":"Alendronate treatment for infants with osteogenesis imperfecta: demonstration of efficacy in a mouse model","volume":"52","author":"McCarthy","year":"2002","journal-title":"Pediatr. Res."},{"issue":"1","key":"10.1016\/j.actbio.2026.04.054_bib0054","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.bone.2004.10.006","article-title":"Differential effects of alendronate treatment on bone from growing osteogenesis imperfecta and wild-type mouse","volume":"36","author":"Misof","year":"2005","journal-title":"Bone"},{"issue":"16","key":"10.1016\/j.actbio.2026.04.054_bib0055","doi-asserted-by":"crossref","first-page":"3371","DOI":"10.1016\/j.jbiomech.2008.09.028","article-title":"Bisphosphonate treatment in the oim mouse model alters bone modeling during growth","volume":"41","author":"Rao","year":"2008","journal-title":"J. Biomech."},{"key":"10.1016\/j.actbio.2026.04.054_bib0056","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.matbio.2015.12.008","article-title":"Raloxifene reduces skeletal fractures in an animal model of osteogenesis imperfecta","volume":"52-54","author":"Berman","year":"2016","journal-title":"Matrix Biol."},{"issue":"4","key":"10.1016\/j.actbio.2026.04.054_bib0057","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1515\/JPEM.1999.12.4.555","article-title":"Bisphosphonates in children with osteogenesis imperfecta may improve bone mineralization but not bone strength. Report of two patients","volume":"12","author":"Rold\u00e1n","year":"1999","journal-title":"J. Pediatr. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.actbio.2026.04.054_bib0058","doi-asserted-by":"crossref","first-page":"e894","DOI":"10.1097\/MJT.0000000000000236","article-title":"Efficacy of bisphosphonates on bone mineral density and fracture rate in patients with osteogenesis imperfecta: a systematic review and meta-analysis","volume":"23","author":"Shi","year":"2016","journal-title":"Am. J. Ther."},{"key":"10.1016\/j.actbio.2026.04.054_bib0059","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/s11914-017-0401-0","article-title":"Long-term bisphosphonate therapy in osteogenesis imperfecta","volume":"15","author":"Biggin","year":"2017","journal-title":"Curr. Osteoporos. Rep."},{"issue":"12","key":"10.1016\/j.actbio.2026.04.054_bib0060","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1002\/jbmr.1719","article-title":"Incidence of atypical nontraumatic diaphyseal fractures of the femur","volume":"27","author":"Dell","year":"2012","journal-title":"J. Bone Miner. Res."},{"issue":"3","key":"10.1016\/j.actbio.2026.04.054_bib0061","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1302\/0301-620X.89B3.18146","article-title":"Subtrochanteric insufficiency fractures in patients on alendronate therapy: a caution","volume":"89","author":"Goh","year":"2007","journal-title":"J. Bone Joint Surg. Br. Vol."},{"issue":"12","key":"10.1016\/j.actbio.2026.04.054_bib0062","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1056\/NEJMc0707493","article-title":"Atypical fractures of the femoral diaphysis in postmenopausal women taking alendronate","volume":"358","author":"Lenart","year":"2008","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.actbio.2026.04.054_bib0063","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.injury.2007.08.036","article-title":"An emerging pattern of subtrochanteric stress fractures: a long-term complication of alendronate therapy?","volume":"39","author":"Kwek","year":"2008","journal-title":"Injury"},{"issue":"5","key":"10.1016\/j.actbio.2026.04.054_bib0064","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/BOT.0b013e318172841c","article-title":"Low-energy femoral shaft fractures associated with alendronate use","volume":"22","author":"Neviaser","year":"2008","journal-title":"J. Orthop. Trauma"},{"issue":"1","key":"10.1016\/j.actbio.2026.04.054_bib0065","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/jbmr.2405","article-title":"Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus","volume":"30","author":"Khan","year":"2015","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.actbio.2026.04.054_bib0066","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/BF01622190","article-title":"Pamidronate: an unrecognized problem in gastrointestinal tolerability","volume":"4","author":"Lufkin","year":"1994","journal-title":"Osteoporos. Int."},{"issue":"14","key":"10.1016\/j.actbio.2026.04.054_bib0067","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1056\/NEJM199610033351403","article-title":"Esophagitis associated with the use of alendronate","volume":"335","author":"De Groen","year":"1996","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.actbio.2026.04.054_bib0068","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/jcb.25266","article-title":"Risks and benefits of bisphosphonate therapies","volume":"117","author":"Reyes","year":"2016","journal-title":"J. Cell. Biochem."},{"issue":"1","key":"10.1016\/j.actbio.2026.04.054_bib0069","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1056\/NEJMc0808738","article-title":"Reports of esophageal cancer with oral bisphosphonate use","volume":"360","author":"Wysowski","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"18","key":"10.1016\/j.actbio.2026.04.054_bib0070","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa067312","article-title":"Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis","volume":"356","author":"Black","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.actbio.2026.04.054_bib0071","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s002230010045","article-title":"A controlled study of the effects of alendronate in a growing mouse model of osteogenesis imperfecta","volume":"69","author":"Camacho","year":"2001","journal-title":"Calcif. Tissue Int."},{"issue":"6","key":"10.1016\/j.actbio.2026.04.054_bib0072","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1002\/jbmr.2172","article-title":"How tough is brittle bone? Investigating osteogenesis imperfecta in mouse bone","volume":"29","author":"Carriero","year":"2014","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.actbio.2026.04.054_bib0073","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.bone.2013.12.020","article-title":"Altered lacunar and vascular porosity in osteogenesis imperfecta mouse bone as revealed by synchrotron tomography contributes to bone fragility","volume":"61","author":"Carriero","year":"2014","journal-title":"Bone"},{"issue":"2","key":"10.1016\/j.actbio.2026.04.054_bib0074","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1172\/JCI118428","article-title":"Bone mineralization in an osteogenesis imperfecta mouse model studied by small-angle x-ray scattering","volume":"97","author":"Fratzl","year":"1996","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.actbio.2026.04.054_bib0075","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S8756-3282(01)00594-4","article-title":"Age-and genotype-dependence of bone material properties in the osteogenesis imperfecta murine model (oim)","volume":"29","author":"Grabner","year":"2001","journal-title":"Bone"},{"key":"10.1016\/j.actbio.2026.04.054_bib0076","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1007\/s002239900412","article-title":"Bone geometry and strength measurements in aging mice with the oim mutation","volume":"62","author":"McBride J","year":"1998","journal-title":"Calcif. Tissue Int."},{"issue":"2","key":"10.1016\/j.actbio.2026.04.054_bib0077","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S8756-3282(00)00311-2","article-title":"Oim mice exhibit altered femur and incisor mineral composition and decreased bone mineral density","volume":"27","author":"Phillips","year":"2000","journal-title":"Bone"},{"issue":"2","key":"10.1016\/j.actbio.2026.04.054_bib0078","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1359\/jbmr.1999.14.2.264","article-title":"The material basis for reduced mechanical properties in oim mice bones","volume":"14","author":"Camacho","year":"1999","journal-title":"J. Bone Miner. Res."},{"issue":"4","key":"10.1016\/j.actbio.2026.04.054_bib0079","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1177\/00037028211055477","article-title":"Infrared spectroscopy-determined bone compositional changes associated with anti-resorptive treatment of the oim\/oim mouse model of osteogenesis imperfecta","volume":"76","author":"Shanas","year":"2022","journal-title":"Appl. Spectrosc."},{"key":"10.1016\/j.actbio.2026.04.054_bib0080","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1007\/s00223-002-1038-1","article-title":"Fourier transform infrared imaging spectroscopy (FT-IRIS) of mineralization in bisphosphonate-treated oim\/oim mice","volume":"72","author":"Camacho","year":"2003","journal-title":"Calcif. Tissue Int."},{"issue":"8","key":"10.1016\/j.actbio.2026.04.054_bib0081","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1007\/s11999-015-4268-z","article-title":"Are changes in composition in response to treatment of a mouse model of osteogenesis imperfecta sex-dependent?","volume":"473","author":"Boskey","year":"2015","journal-title":"Clin. Orthop. Relat. Res.\u00ae."},{"issue":"3","key":"10.1016\/j.actbio.2026.04.054_bib0082","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S8756-3282(02)00974-2","article-title":"Alendronate affects long bone length and growth plate morphology in the oim mouse model for Osteogenesis Imperfecta","volume":"32","author":"Evans","year":"2003","journal-title":"Bone"},{"issue":"2","key":"10.1016\/j.actbio.2026.04.054_bib0083","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3109\/03008200903108472","article-title":"RANKL inhibition improves bone properties in a mouse model of osteogenesis imperfecta","volume":"51","author":"Bargman","year":"2010","journal-title":"Connect. Tissue Res."},{"key":"10.1016\/j.actbio.2026.04.054_bib0084","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1007\/s00198-011-1742-7","article-title":"Comparable outcomes in fracture reduction and bone properties with RANKL inhibition and alendronate treatment in a mouse model of osteogenesis imperfecta","volume":"23","author":"Bargman","year":"2012","journal-title":"Osteoporos. Int."},{"issue":"2","key":"10.1016\/j.actbio.2026.04.054_bib0085","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/jor.20469","article-title":"The effects of RANKL inhibition on fracture healing and bone strength in a mouse model of osteogenesis imperfecta","volume":"26","author":"Delos","year":"2008","journal-title":"J. Orthop. Res."},{"issue":"7","key":"10.1016\/j.actbio.2026.04.054_bib0086","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.exphem.2010.04.008","article-title":"Amelioration of a mouse model of osteogenesis imperfecta with hematopoietic stem cell transplantation: microcomputed tomography studies","volume":"38","author":"Mehrotra","year":"2010","journal-title":"Exp. Hematol."},{"issue":"3","key":"10.1016\/j.actbio.2026.04.054_bib0087","first-page":"1053","article-title":"Transplantation of human fetal blood stem cells in the osteogenesis imperfecta mouse leads to improvement in multiscale tissue properties","volume":"117","author":"Vanleene","year":"2011","journal-title":"Blood, J. Am. Soc. Hematol."},{"issue":"5","key":"10.1016\/j.actbio.2026.04.054_bib0088","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1073\/pnas.90.5.1701","article-title":"Defective pro alpha 2 (I) collagen synthesis in a recessive mutation in mice: a model of human osteogenesis imperfecta","volume":"90","author":"Chipman","year":"1993","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"4","key":"10.1016\/j.actbio.2026.04.054_bib0089","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1136\/jmg.21.4.257","article-title":"The clinical features of homozygous alpha 2 (I) collagen deficient osteogenesis imperfecta","volume":"21","author":"Nicholls","year":"1984","journal-title":"J. Med. Genet."},{"issue":"6","key":"10.1016\/j.actbio.2026.04.054_bib0090","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S8756-3282(96)00305-5","article-title":"Heterozygous oim mice exhibit a mild form of osteogenesis imperfecta","volume":"19","author":"Saban","year":"1996","journal-title":"Bone"},{"key":"10.1016\/j.actbio.2026.04.054_bib0091","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1007\/s10439-013-0793-7","article-title":"Gender-dependence of bone structure and properties in adult osteogenesis imperfecta murine model","volume":"41","author":"Yao","year":"2013","journal-title":"Ann. Biomed. Eng."},{"key":"10.1016\/j.actbio.2026.04.054_bib0092","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmbbm.2021.104377","article-title":"Intrafibrillar mineralization deficiency and osteogenesis imperfecta mouse bone fragility","volume":"117","author":"Maghsoudi-Ganjeh","year":"2021","journal-title":"J. Mech. Behav. Biomed. Mater."},{"issue":"Suppl 5","key":"10.1016\/j.actbio.2026.04.054_bib0093","first-page":"16","article-title":"Bone mineral crystal size","volume":"14","author":"Boskey","year":"2003","journal-title":"Osteoporos. Int."},{"issue":"6","key":"10.1016\/j.actbio.2026.04.054_bib0094","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.bone.2012.03.007","article-title":"Ultra-structural defects cause low bone matrix stiffness despite high mineralization in osteogenesis imperfecta mice","volume":"50","author":"Vanleene","year":"2012","journal-title":"Bone"},{"issue":"9","key":"10.1016\/j.actbio.2026.04.054_bib0095","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.049428","article-title":"Collagen (I) homotrimer potentiates the osteogenesis imperfecta (oim) mutant allele and reduces survival in male mice","volume":"15","author":"Lee","year":"2022","journal-title":"Disease Models Mech."},{"key":"10.1016\/j.actbio.2026.04.054_bib0096","series-title":"American College of Laboratory Animal Medicine series","first-page":"637","article-title":"The mouse in biomedical research","author":"Flurkey","year":"2007"},{"key":"10.1016\/j.actbio.2026.04.054_bib0097","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jmbbm.2014.06.017","article-title":"A methodology for the investigation of toughness and crack propagation in mouse bone","volume":"39","author":"Carriero","year":"2014","journal-title":"J. Mech. Behav. Biomed. Mater."},{"key":"10.1016\/j.actbio.2026.04.054_bib0098","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.bone.2014.09.020","article-title":"Reference point indentation is not indicative of whole mouse bone measures of stress intensity fracture toughness","volume":"69","author":"Carriero","year":"2014","journal-title":"Bone"},{"key":"10.1016\/j.actbio.2026.04.054_bib0099","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s00223-017-0248-5","article-title":"Altered bone mechanics, architecture and composition in the skeleton of TIMP-3-deficient mice","volume":"100","author":"Miller","year":"2017","journal-title":"Calcif. Tissue Int."},{"issue":"193","key":"10.1016\/j.actbio.2026.04.054_bib0100","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3006286","article-title":"Vitamin D deficiency induces early signs of aging in human bone, increasing the risk of fracture","volume":"5","author":"Busse","year":"2013","journal-title":"Sci. Transl. Med."},{"issue":"3","key":"10.1016\/j.actbio.2026.04.054_bib0101","article-title":"Age and sex differences in load induced tibial cortical bone surface strain maps","volume":"5","author":"Carriero","year":"2021","journal-title":"J. Bone Miner. Res. Plus"},{"key":"10.1016\/j.actbio.2026.04.054_bib0102","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.bonr.2018.02.003","article-title":"Spatial relationship between bone formation and mechanical stimulus within cortical bone: combining 3D fluorochrome mapping and poroelastic finite element modelling","volume":"8","author":"Carriero","year":"2018","journal-title":"Bone Rep."},{"issue":"1","key":"10.1016\/j.actbio.2026.04.054_bib0103","doi-asserted-by":"crossref","first-page":"6636","DOI":"10.1038\/s41598-018-25084-6","article-title":"Transient peak-strain matching partially recovers the age-impaired mechanoadaptive cortical bone response","volume":"8","author":"Javaheri","year":"2018","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.actbio.2026.04.054_bib0104","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0167971","article-title":"Overexpression of TIMP-3 in chondrocytes produces transient reduction in growth plate length but permanently reduces adult bone quality and quantity","volume":"11","author":"Poulet","year":"2016","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.actbio.2026.04.054_bib0105","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1016\/j.jbiomech.2014.03.035","article-title":"Ex vivo determination of bone tissue strains for an in vivo mouse tibial loading model","volume":"47","author":"Carriero","year":"2014","journal-title":"J. Biomech."},{"key":"10.1016\/j.actbio.2026.04.054_bib0106","series-title":"Standard Test Method For Measurement of Fracture Toughness","year":"2019"},{"key":"10.1016\/j.actbio.2026.04.054_bib0107","series-title":"Annual Book of Americal Society For Testing and Material Standards","article-title":"Standard test method for flexural properties of reinforced plastics and electrical insulation materials","year":"2010"},{"issue":"5","key":"10.1016\/j.actbio.2026.04.054_bib0108","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.bone.2008.04.027","article-title":"Measurement of the toughness of bone: a tutorial with special reference to small animal studies","volume":"43","author":"Ritchie","year":"2008","journal-title":"Bone"},{"issue":"6","key":"10.1016\/j.actbio.2026.04.054_bib0109","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1107\/S160057751601479X","article-title":"Analytical formula for two-dimensional ring artefact suppression","volume":"23","author":"Titarenko","year":"2016","journal-title":"J. Synchrotron Rad."},{"key":"10.1016\/j.actbio.2026.04.054_bib0110","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2024.1497837","article-title":"FiberO for an automated quantitative analysis of fibers orientation and organization in biological fibrous tissues","volume":"12","author":"Mu\u00f1oz","year":"2025","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"5","key":"10.1016\/j.actbio.2026.04.054_bib0111","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0154700","article-title":"Advanced glycation endproducts and bone material properties in type 1 diabetic mice","volume":"11","author":"Rubin","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.actbio.2026.04.054_bib0112","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jmbbm.2015.08.012","article-title":"A direct role of collagen glycation in bone fracture","volume":"52","author":"Poundarik","year":"2015","journal-title":"J. Mech. Behav. Biomed. Mater."},{"key":"10.1016\/j.actbio.2026.04.054_bib0113","series-title":"Clinical Biochemistry: Metabolic and Clinical Aspects (Third Edition)","first-page":"604","article-title":"CHAPTER 31 - metabolic bone disease","author":"Cundy","year":"2014"},{"key":"10.1016\/j.actbio.2026.04.054_bib0114","series-title":"Discovering Statistics Using IBM SPSS Statistics","author":"Field","year":"2024"},{"issue":"2","key":"10.1016\/j.actbio.2026.04.054_bib0115","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3758\/BF03193146","article-title":"G* Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences","volume":"39","author":"Faul","year":"2007","journal-title":"Behav. Res. Methods"},{"issue":"4","key":"10.1016\/j.actbio.2026.04.054_bib0116","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.3758\/BRM.41.4.1149","article-title":"Statistical power analyses using G* Power 3.1: tests for correlation and regression analyses","volume":"41","author":"Faul","year":"2009","journal-title":"Behav. Res. Methods"},{"issue":"1\u20132","key":"10.1016\/j.actbio.2026.04.054_bib0117","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1080\/09243860500095471","article-title":"Microcracks colocalize within highly mineralized regions of cortical bone tissue","volume":"42","author":"Wasserman","year":"2005","journal-title":"Eur. J. Morphol."},{"issue":"3","key":"10.1016\/j.actbio.2026.04.054_bib0118","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/1097-4636(20000905)51:3<504::AID-JBM27>3.0.CO;2-I","article-title":"Calculation of porosity and osteonal cement line effects on the effective fracture toughness of cortical bone in longitudinal crack growth","volume":"51","author":"Yeni","year":"2000","journal-title":"J. Biomed. Mater. Res."},{"key":"10.1016\/j.actbio.2026.04.054_bib0119","series-title":"Transactions of the Annual Meeting of the Orthopaedic Research Society","article-title":"Age effect on bone toughness in osteogenesis imperfecta","author":"Docaj","year":"2020"},{"key":"10.1016\/j.actbio.2026.04.054_bib0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2025.117613","article-title":"Osteocyte-lacuna shape and canaliculi architecture dictate fluid flow around osteocyte, and strain of cell and bone matrix: implications for cell mechanobiology and bone fragility","author":"Mu\u00f1oz","year":"2025","journal-title":"Bone"},{"issue":"6","key":"10.1016\/j.actbio.2026.04.054_bib0121","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s00223-024-01263-8","article-title":"Bone quality and mineralization and effects of treatment in osteogenesis imperfecta","volume":"115","author":"Misof","year":"2024","journal-title":"Calcif. Tissue Int."},{"issue":"4","key":"10.1016\/j.actbio.2026.04.054_bib0122","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.bone.2011.12.026","article-title":"Age-specific profiles of tissue-level composition and mechanical properties in murine cortical bone","volume":"50","author":"Raghavan","year":"2012","journal-title":"Bone"},{"issue":"13","key":"10.1016\/j.actbio.2026.04.054_bib0123","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s10354-015-0369-2","article-title":"Bone mass and mineralization in osteogenesis imperfecta","volume":"165","author":"Fratzl-Zelman","year":"2015","journal-title":"Wiener Medizinische Wochenschrift"},{"key":"10.1016\/j.actbio.2026.04.054_bib0124","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.bone.2014.04.030","article-title":"Mechanical and mineral properties of osteogenesis imperfecta human bones at the tissue level","volume":"65","author":"Imbert","year":"2014","journal-title":"Bone"},{"issue":"5","key":"10.1016\/j.actbio.2026.04.054_bib0125","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1002\/jbmr.2780","article-title":"Evidence for a role for nanoporosity and pyridinoline content in human mild osteogenesis imperfecta","volume":"31","author":"Paschalis","year":"2016","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.actbio.2026.04.054_bib0126","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.bone.2014.12.023","article-title":"Unique micro-and nano-scale mineralization pattern of human osteogenesis imperfecta type VI bone","volume":"73","author":"Fratzl-Zelman","year":"2015","journal-title":"Bone."},{"issue":"4","key":"10.1016\/j.actbio.2026.04.054_bib0127","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0945-053X(94)90200-3","article-title":"Ultrastructural studies of bones from patients with osteogenesis imperfecta","volume":"14","author":"Traub","year":"1994","journal-title":"Matrix Biol."},{"key":"10.1016\/j.actbio.2026.04.054_bib0128","article-title":"Histopathology of osteogenesis imperfecta bone. Supramolecular assessment of cells and matrices in the context of woven and lamellar bone formation using light, polarization and ultrastructural microscopy","volume":"14","author":"Shapiro","year":"2021","journal-title":"Bone Rep."},{"key":"10.1016\/j.actbio.2026.04.054_bib0129","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2025.117495","article-title":"Small and porous ossicles, with flat stapes footplate and incudal fractures in the oim mouse model of osteogenesis imperfecta","volume":"196","author":"Ugarteburu","year":"2025","journal-title":"Bone"},{"key":"10.1016\/j.actbio.2026.04.054_bib0130","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2021.705505","article-title":"Gender-related impact of sclerostin antibody on bone in the Osteogenesis Imperfecta mouse","volume":"12","author":"Cardinal","year":"2021","journal-title":"Front. Genet."},{"key":"10.1016\/j.actbio.2026.04.054_bib0131","article-title":"Effect of bisphosphonate treatment on the oim mouse middle ear ossicles' structure, composition and hearing","author":"Ugarteburu","year":"2025","journal-title":"Bone"},{"key":"10.1016\/j.actbio.2026.04.054_bib0132","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1146\/annurev-matsci-070909-104427","article-title":"On the mechanistic origins of toughness in bone","volume":"40","author":"Launey","year":"2010","journal-title":"Annu. Rev. Mater. Res."},{"issue":"1","key":"10.1016\/j.actbio.2026.04.054_bib0133","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1749-6632.2009.05232.x","article-title":"How does human bone resist fracture?","volume":"1192","author":"Ritchie","year":"2010","journal-title":"Ann New York Acad. Sci."},{"issue":"6","key":"10.1016\/j.actbio.2026.04.054_bib0134","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1063\/1.3156332","article-title":"Plasticity and toughness in bone","volume":"62","author":"Ritchie","year":"2009","journal-title":"Phys. Today"},{"key":"10.1016\/j.actbio.2026.04.054_bib0135","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/s11837-012-0298-0","article-title":"The multiscale origins of fracture resistance in human bone and its biological degradation","volume":"64","author":"Zimmermann","year":"2012","journal-title":"Jom."},{"issue":"20","key":"10.1016\/j.actbio.2026.04.054_bib0136","doi-asserted-by":"crossref","first-page":"5297","DOI":"10.1016\/j.biomaterials.2010.03.056","article-title":"The significance of crack-resistance curves to the mixed-mode fracture toughness of human cortical bone","volume":"31","author":"Zimmermann","year":"2010","journal-title":"Biomaterials"},{"issue":"6","key":"10.1016\/j.actbio.2026.04.054_bib0137","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.bone.2004.07.016","article-title":"Effect of aging on the toughness of human cortical bone: evaluation by R-curves","volume":"35","author":"Nalla","year":"2004","journal-title":"Bone"},{"key":"10.1016\/j.actbio.2026.04.054_bib0138","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmbbm.2022.105155","article-title":"Impact of test environment on the fracture resistance of cortical bone","volume":"129","author":"Shin","year":"2022","journal-title":"J. Mech. Behav. Biomed. Mater."},{"key":"10.1016\/j.actbio.2026.04.054_bib0139","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmbbm.2024.106468","article-title":"A numerical study of dehydration induced fracture toughness degradation in human cortical bone","volume":"153","author":"Shin","year":"2024","journal-title":"J. Mech. Behav. Biomed. Mater."},{"issue":"3","key":"10.1016\/j.actbio.2026.04.054_bib0140","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1124\/jpet.102.035295","article-title":"Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid","volume":"302","author":"Wood","year":"2002","journal-title":"J. Pharmacol. Exp. Therap."},{"issue":"1","key":"10.1016\/j.actbio.2026.04.054_bib0141","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-43377-3","article-title":"The bisphosphonates alendronate and zoledronate induce adaptations of aerobic metabolism in permanent human endothelial cells","volume":"13","author":"Budzinska","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.actbio.2026.04.054_bib0142","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s00198-007-0533-7","article-title":"Bisphosphonates alter trabecular bone collagen cross-linking and isomerization in beagle dog vertebra","volume":"19","author":"Allen","year":"2008","journal-title":"Osteoporos. Int."},{"issue":"8","key":"10.1016\/j.actbio.2026.04.054_bib0143","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1138\/20090390","article-title":"Advanced glycation end-products and bone fractures","volume":"6","author":"Vashishth","year":"2009","journal-title":"Ibms Bonekey."},{"key":"10.1016\/j.actbio.2026.04.054_bib0144","article-title":"Zebra lines in osteogenesis imperfecta on bisphosphonate therapy","volume":"2013","author":"Sukumar","year":"2013","journal-title":"Case Rep."},{"issue":"01","key":"10.1016\/j.actbio.2026.04.054_bib0145","doi-asserted-by":"crossref","first-page":"42","DOI":"10.4103\/0971-3026.59752","article-title":"Metaphyseal bands in osteogenesis imperfecta","volume":"20","author":"Suresh","year":"2010","journal-title":"Indian J. Radiol. Imaging"},{"issue":"4","key":"10.1016\/j.actbio.2026.04.054_bib0146","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.radcr.2017.07.003","article-title":"Pamidronate \u201czebra lines\u201d: a treatment timeline","volume":"12","author":"Loizidou","year":"2017","journal-title":"Radiol. Case Rep."},{"key":"10.1016\/j.actbio.2026.04.054_bib0147","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1007\/s12098-017-2316-2","article-title":"Characteristic bands manifesting as zebra lines on radiographs in osteogenesis imperfecta","volume":"84","author":"Ishizuka","year":"2017","journal-title":"Indian J. Pediatr."},{"issue":"1","key":"10.1016\/j.actbio.2026.04.054_bib0148","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1148\/radiology.184.1.1609087","article-title":"Epi-and metaphyseal changes in children caused by administration of bisphosphonates","volume":"184","author":"Van Persijn van Meerten","year":"1992","journal-title":"Radiology"},{"issue":"7","key":"10.1016\/j.actbio.2026.04.054_bib0149","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1359\/JBMR.040303","article-title":"Sclerotic metaphyseal lines in a child treated with pamidronate: histomorphometric analysis","volume":"19","author":"Rauch","year":"2004","journal-title":"J. Bone Miner. Res."}],"container-title":["Acta Biomaterialia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706126002746?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706126002746?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T02:54:13Z","timestamp":1783047253000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1742706126002746"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":149,"alternative-id":["S1742706126002746"],"URL":"https:\/\/doi.org\/10.1016\/j.actbio.2026.04.054","relation":{},"ISSN":["1742-7061"],"issn-type":[{"value":"1742-7061","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bone fragility persists in long-term bisphosphonate-treated oim mice despite sex-specific changes in bone quality","name":"articletitle","label":"Article Title"},{"value":"Acta Biomaterialia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actbio.2026.04.054","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Acta Materialia Inc. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}